PinUp: Digital Disruption of Pharma Communications with Physicians, More…
Welcome to the May 19, 2017, issue of Pharma Industry News Update (aka PinUp). Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era.
PinUp: Physician Marketing vs. Education, Digital Transformation, Faith in Sales Reps, More…
Welcome to the May 16, 2017, issue of Pharma Industry News Update (aka PinUp). On the one hand, #pharmaceutical executives defend sales reps, but in the other hand tell you about the success of non-personal communications, especially with
PinUp: Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma
Welcome to the May 12, 2017, issue of Pharma Industry News Update (aka PinUp). The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn't work it took more drastic action.
PinUp: mHealth Apps “Unfit” for Cancer Survivors, Digital Pharma Transformation, Vertical Video Twitter Ads
Welcome to the May 9, 2017, issue of Pharma Industry News Update (aka PinUp).
PinUp: Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians
Welcome to the May 5, 2017, issue of Pharma Industry News Update (aka PinUp). Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing.
PinUp: Open Letter to Gottlieb, Adherence Challenges Infographic, Pharma Social Media Trends
Welcome to the May 2, 2017, issue of Pharma Industry News Update (aka PinUp).
Pharma and Patient Advocacy Groups: Patient Centricity Finally Pays Off for Both
The big patient-centricity payoff for pharma is its relationship with patient advocacy groups that are recruited to lobby Congress, local governments and the FDA.
The Alternate Reality of Pharma CEOs: Their Views Regarding Drug Prices, Innovation, Taxes &...
Drug industry CEOs are busy talking publicly about drug prices, taxes, innovations, and other issues that need defending. Their arguments are highlighted in this article.
Limiting Sales Rep Access to Physicians: Do the Benefits Outweigh the Risks?
This article documents the concerns about the risks of drug sales reps as well as the benefits to physicians.
PinUp: Silicon Valley Health Venture Woes and Pharma Ups Its Influence in Washington
Welcome to the April 28, 2017, issue of Pharma Industry News Update (aka PinUp). The pharma industry lags other industries in its investment in digital technology. Silicon valley startups rush in to fill the void but have trouble raising funds due to hype and deception.
